Modified Low Density Lipoprotein and Lipoprotein-Containing Circulating Immune Complexes as Diagnostic and Prognostic Biomarkers of Atherosclerosis and Type 1 Diabetes Macrovascular Disease

In atherosclerosis; blood low-density lipoproteins (LDL) are subjected to multiple enzymatic and non-enzymatic modifications that increase their atherogenicity and induce immunogenicity. Modified LDL are capable of inducing vascular inflammation through activation of innate immunity; thus, contribut...

Descripción completa

Detalles Bibliográficos
Autores principales: Orekhov, Alexander N., Bobryshev, Yuri V., Sobenin, Igor A., Melnichenko, Alexandra A., Chistiakov, Dimitry A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139876/
https://www.ncbi.nlm.nih.gov/pubmed/25050779
http://dx.doi.org/10.3390/ijms150712807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139876/
https://www.ncbi.nlm.nih.gov/pubmed/25050779
http://dx.doi.org/10.3390/ijms150712807

Ejemplares similares